AAP
ETRM

Ardsley Advisory Partners’s EnteroMedics Inc. ETRM Stock Holding History

Ardsley Advisory Partners’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-286
Closed -$468K – 323
2014
Q2 		$468K Sell
286
-3,443
-92% -$6.44M 0.06% 164
2014
Q1 		$7.13M Sell
3,729
-366
-9% -$867K 1.07% 33
2013
Q4 		$8.77M Buy
4,095
+524
+15% +$845K 1.17% 21
2013
Q3 		$4.67M Buy
3,571
+157
+5% +$183K 0.95% 31
2013
Q2 		$4.09M Buy
+3,414
New +$3.61M 0.9% 36

Other funds holding ETRM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Ardsley Advisory Partners's ETRM Position: Q3 2014 in Review

Ardsley Advisory Partners sold out of EnteroMedics Inc. (ETRM) in Q3 2014, closing a stake of 286 shares — an estimated $468K sold.

Ardsley Advisory Partners first reported a position in ETRM in Q2 2013 and held it in 5 quarters. The position peaked at $8.77M in Q4 2013. 49 funds tracked by Wall St. Rank hold ETRM as of Q3 2014.

  • Ardsley Advisory Partners reported no remaining EnteroMedics Inc. position as of Q3 2014 after selling out during the quarter.
  • Ardsley Advisory Partners sold 286 EnteroMedics Inc. shares in Q3 2014, an estimated $468K.
  • Ardsley Advisory Partners first reported a position in EnteroMedics Inc. in Q2 2013 and held it in 5 quarters.
  • Ardsley Advisory Partners's EnteroMedics Inc. position peaked at $8.77M in Q4 2013.
  • 49 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q3 2014.

Based on Ardsley Advisory Partners's 13F filing for Q3 2014, filed 13 Nov 2014.